Serum lipids and hippocampal volume: The link to Alzheimer's disease?
@article{Wolf2004SerumLA,
title={Serum lipids and hippocampal volume: The link to Alzheimer's disease?},
author={Henrike Wolf and Anke Hensel and Thomas Arendt and Miia Kivipelto and Bengt Winblad and H. -J. Gertz},
journal={Annals of Neurology},
year={2004},
volume={56}
}The association between hippocampal volume (as a presumed index of Alzheimer's disease pathology) with serum total cholesterol, high‐density lipoprotein cholesterol, and low‐density lipoprotein cholesterol was studied in 86 elderly subjects with a range of cognitive functions. High‐density lipoprotein cholesterol, but not low‐density lipoprotein cholesterol or total cholesterol, was associated with hippocampal volume and dementia. This is compatible with protective effects of high‐density…
41 Citations
Relationship between cholesterol metabolism, ApoE and brain volumes in Alzheimer's disease
- Biology, Medicine
- 2011
Significant correlations were found between cholesterol precursors lathosterol, lanosterol and 24S-hydroxycholesterol (a putative marker of brain cholesterol turnover) in plasma and brain atrophy as quantified by MRI.
Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review
- BiologyCureus
- 2020
An association between plasma lipids, polymorphisms in genes associated with cholesterol transport, and Alzheimer's disease is found, proving that plasmalipids can be used as biomarkers for early diagnosis of Alzheimer’s disease.
Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers.
- BiologyJournal of Alzheimer's disease : JAD
- 2009
A novel negative association between HDL and Abeta is reported, which if demonstrated to be causal has implications for the development of lifestyle interventions and/or novel therapeutics.
Low-Density Lipoprotein Cholesterol and Alzheimer's Disease: A Systematic Review and Meta-Analysis
- Biology, MedicineFrontiers in Aging Neuroscience
- 2020
Elevated concentration of LDL-c (>121 mg/dl) may be a potential risk factor for AD, and this association is strong in patients aged 60–70 years, but vanishes with advancing age.
High‐density lipoprotein‐related cholesterol metabolism in Alzheimer’s disease
- BiologyJournal of neurochemistry
- 2020
The pathway that leads to HDL formation and its subsequent remodelling and catabolism is discussed with regards to the possible involvement of HDL ‘protein cargo’ in Alzheimer's disease.
Elevated HDL Levels Linked to Poorer Cognitive Ability in Females With Parkinson’s Disease
- Biology, PsychologyFrontiers in Aging Neuroscience
- 2021
Higher serum HDL associates with poorer cognitive function in females with PD and presents a sex-specific biomarker for cognitive impairment in PD.
Cholesterol and Late-Life Cognitive Decline
- Psychology, Biology
- 2012
Factors that influence cholesterol metabolism, such as dietary intake, are shown to play a role in late-life cognitive function and the risk of dementia, but the association is strongly age-dependent.
The influence of age on the association between cholesterol and cognitive function
- Medicine, PsychologyExperimental Gerontology
- 2009
Circulating biomarkers of cognitive decline and dementia.
- Biology, MedicineClinica chimica acta; international journal of clinical chemistry
- 2006
References
SHOWING 1-10 OF 19 REFERENCES
Association between high‐density lipoprotein and cognitive impairment in the oldest old
- MedicineAnnals of neurology
- 2002
At least part of the association between high‐density lipoprotein cholesterol and cognitive function is independent of atherosclerotic disease, and this association is associated with cognitive impairment and dementia.
Relationships between Cholesterol, Apolipoprotein E Polymorphism and Dementia: A Cross-Sectional Analysis from the PAQUID Study
- MedicineNeuroepidemiology
- 2000
Elevated high-density lipoprotein cholesterol was associated with a significantly decreased risk of dementia, independent of apoE status and other potential confounding variables, suggesting that cholesterol fractions could be involved in both Alzheimer’s disease and vascular dementia.
Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer’s disease☆
- BiologyNeurobiology of Aging
- 2000
Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype
- Biology, Medicine
- 2000
CSF LPs from healthy, cognitively normal, fasted, elderly individuals at different risk for AD based on ApoE genotype were characterized and plasma and CSF high‐density lipoprotein (HDL) cholesterol and apolipoprotein AI (ApoAI) levels were correlated.
Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
- Biology, MedicineAnnals of neurology
- 2000
CSF LPs from healthy, cognitively normal, fasted, elderly individuals at different risk for AD based on ApoE genotype were characterized and plasma and CSF high-density lipoprotein (HDL) cholesterol and apolipoprotein AI (ApoAI) levels were correlated.
The effect of APOE on dementia is not through atherosclerosis: the Rotterdam Study.
- Medicine, PsychologyNeurology
- 1999
This study suggests that atherosclerosis is not an intermediate factor in the association of APOE with dementia, as neither adjusting nor stratification for Atherosclerosis altered the association.
Homocysteine and brain atrophy on MRI of non-demented elderly.
- Biology, PsychologyBrain : a journal of neurology
- 2003
The hypothesis that higher plasma homocysteine levels are associated with more atrophy of the hippocampus and cortical regions in elderly at risk of Alzheimer's disease is supported.
Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids.
- BiologyClinica chimica acta; international journal of clinical chemistry
- 1998
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study.
- MedicineBMJ
- 2001
Raised systolic blood pressure and high serum cholesterol concentration, and in particular the combination of these risks, in midlife increase the risk of Alzheimer's disease in later life.
Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model
- BiologyNeurobiology of Disease
- 2000
It is proposed that diet can be used to modulate the risk of developing AD and high dietary cholesterol increases Aβ accumulation and accelerates the AD-related pathology observed in this animal model.